Treatment of high-risk neuroblastoma

Treatment of high-risk neuroblastoma

Although high-dose chemotherapy and autologous stem cell transplantation (HDCT/autoSCT) have improved the prognosis for patients with high-risk neuroblastoma (NB), event-free survival rates remain in the range of 30 to 40%, which is unsatisfactory. To further improve outcomes, several clinical trial...

Full description

Bibliographic Details
Main Author:	Ki Woong Sung
Format:	Article
Language:	English
Published:	Korean Pediatric Society 2012-04-01
Series:	Korean Journal of Pediatrics
Subjects:	Neuroblastoma High-dose chemotherapy Allogeneic stem cell transplantation
Online Access:	http://kjp.or.kr/upload/pdf/kjped-55-115.pdf

Similar Items

Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 study
by: Ji Won Lee, et al.
Published: (2017-05-01)

I-131-Metaiodobenzylguanidine therapy with allogeneic cord blood stem cell transplantation for recurrent neuroblastoma
by: Sato Yuya, et al.
Published: (2012-10-01)

Pediatric high risk neuroblastoma with autologous stem cell transplant – 20 years of experience
by: Saadiya Khan, et al.
Published: (2021-12-01)

Pulmonary Exacerbation of Undiagnosed Toxocariasis in Intensively-Treated High-Risk Neuroblastoma Patients
by: Szymon Janczar, et al.
Published: (2020-10-01)

Stem Cell Transplantation in Neuroblastoma: Iranian Experience
by: Amir Ali Hamidieh, et al.
Published: (2009-06-01)

Stem Cell Transplantation in Neuroblastoma: Iranian Experience
by: Amir Ali Hamidieh, et al.
Published: (2009-04-01)

High-Risk Neuroblastoma Treatment Review
by: Valeria Smith, et al.
Published: (2018-08-01)

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in the treatment of children and adolescents with Ewing sarcoma family of tumors
by: Juhee Seo, et al.
Published: (2013-09-01)

Metastatic Burden Defines Clinically and Biologically Distinct Subgroups of Stage 4 High-Risk Neuroblastoma
by: Eun Seop Seo, et al.
Published: (2020-08-01)

Russian multicenter clinical trials in acute leukemias
by: E N Parovichnikova, et al.
Published: (2019-07-01)

Population Pharmacokinetics of Caspofungin and Dosing Optimization in Children With Allogeneic Hematopoietic Stem Cell Transplantation
by: Chang-He Niu, et al.
Published: (2020-03-01)

Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody Treatment
by: Christian Martin Seitz, et al.
Published: (2021-07-01)

Interaction of bone marrow-derived mesenchymal stem cells on neuroblastoma cells
by: Kwong, Rebecca Sze-Wai.
Published: (2013)

Oral Metronomic Maintenance Therapy Can Improve Survival in High-Risk Neuroblastoma Patients Not Treated with ASCT or Anti-GD2 Antibodies
by: Xiaofei Sun, et al.
Published: (2021-07-01)

Aggressive Neuroblastoma in a Pediatric Patient with Severe Hemophilia A
by: Lidia Costa, et al.
Published: (2021-03-01)

A Very Rare Adult Case with Neuroblastoma
by: Fatih Selcukbiricik, et al.
Published: (2011-09-01)

Factors Modifying Outcome After MIBG Therapy in Children With Neuroblastoma—A National Retrospective Study
by: Marek Ussowicz, et al.
Published: (2021-04-01)

Sarcopenia and preserved bone mineral density in paediatric survivors of high‐risk neuroblastoma with growth failure
by: Michelle Guo, et al.
Published: (2021-08-01)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant? (Running Title: The Role of Salvage alloSCT in MM)
by: Hyunkyung Park, et al.
Published: (2020-07-01)

Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure
by: Mireia Uribe-Herranz, et al.
Published: (2021-01-01)

The effectiveness of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in the treatment
by: T. V. Yukhta, et al.
Published: (2019-12-01)

Mabtera (rituximab) treatment of patients with refractory' course of B-cell lymphoma on high-dose chemotherapy with autologous transplantation of hemopoiesis precursor cells
by: V V Ptushkin, et al.
Published: (2003-01-01)

Effectiveness of Prophylactic Fluconazole at Low Doses for Allogeneic Hematopoietic Stem Cell Transplant Patients
by: Hunt, Lawrence Taylor, et al.
Published: (2016)

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients
by: N. V. Zhukov, et al.
Published: (2014-07-01)

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients
by: N. V. Zhukov, et al.
Published: (2014-07-01)

High-dose chemotherapy following autologous hematopoietic stem cell transplantation for multiple myeloma in the real world setting. Single-center experience
by: Nikita E. Mochkin, et al.
Published: (2020-07-01)

Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis
by: Panagiotis Karagiannis, et al.
Published: (2020-06-01)

Outcome of Classical Hodgkin’s Lymphoma Treatment Based on High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Experience in the NI Pirogov Russian National Medical Center of Surgery
by: NE Mochkin, et al.
Published: (2018-07-01)

Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol
by: Raita Araki, et al.
Published: (2018-06-01)

Allogeneic transplantation in multiple myeloma Transplante alogênico no mieloma múltiplo
by: Ignazio Majolino, et al.
Published: (2009-08-01)

Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis
by: Marek Ussowicz, et al.
Published: (2020-12-01)

Treatment of multiple myeloma patients with autologous stem cell transplantation — a fresh analysis
by: Malgorzata Wach, et al.
Published: (2011-07-01)

Transcriptional Profiling Reveals a Common Metabolic Program in High-Risk Human Neuroblastoma and Mouse Neuroblastoma Sphere-Forming Cells
by: Mengling Liu, et al.
Published: (2016-10-01)

Treatment of multiple myeloma patients with autologous stem cell transplantation &#8212; a fresh analysis
by: Anna Dmoszynska, et al.
Published: (2011-07-01)

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010
by: Ardeshir Ghavamzadeh, et al.
Published: (2010-12-01)

Hematopoietic Stem Cell Transplantation in Iran: 1991 through 2010
by: Ardeshir Ghavamzadeh, et al.
Published: (2010-10-01)

Hematopoietic stem cell transplantation: clinical use and perspectives
by: Francisco Barriga, et al.
Published: (2012-01-01)

THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
by: V. A. Lyashenko, et al.
Published: (2014-07-01)

THE INFLUENCE OF STEM CELLS ON EARLY STAGES OF THE GRAFT IMMUNITY
by: V. A. Lyashenko, et al.
Published: (2014-07-01)

Characterisation of the alloresponse to defined HLA mismatches in volunteer unrelated donor stem cell transplantation
by: Brookes, Paul Anthony
Published: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ih3ht40f8d0r9r4hjte0h9uuq4